N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma

Clinical Cancer Research

Volumn 10, Issue 12 I, 2004, Pages 4125-4133

  Nakajima, Sanae ^a   Doi, Ryuichiro ^a   Toyoda, Eiji ^a   Tsuji, Shoichiro ^a   Wada, Michihiko ^a   Koizumi, Masayuki ^a   Tulachan, Sidhartha S ^a   Ito, Daisuke ^a   Kami, Kazuhiro ^a   Mori, Tomohiko ^a   Kawaguchi, Yoshiya ^a   Fujimoto, Koji ^a   Hosotani, Ryo ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; FIBROBLAST GROWTH FACTOR 2; NERVE CELL ADHESION MOLECULE; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL CULTURE; CONTROLLED STUDY; EPITHELIAL TO MESENCHYMAL TRANSITION; EPITHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME; METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

AGED; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; CELL PROLIFERATION; EPITHELIUM; FIBROBLAST GROWTH FACTOR 2; HUMANS; IMMUNOHISTOCHEMISTRY; MESODERM; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREAS; PANCREATIC NEOPLASMS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VIMENTIN;

EID: 3042618951     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0578-03     Document Type: Article

References (48)

1. Kim JB, Islam S, Kim YJ, et al. N-Cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 2000;151:1193-206.
2. Karayiannakis AJ, Syrigos KN, Polychronidis A, Simopoulos C. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis. Anticancer Res 2001;21:4127-34.
3. Joo YE, Rew JS, Park CS, Kim SJ. Expression of E-cadherin, alpha- and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology 2002;2:129-37.
4. Richmond PJ, Karayiannakis AJ, Nagafuchi A, Kaisary AV, Pignatelli M. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. Cancer Res 1997;57:3189-93.
5. Karatzas G, Karayiannakis AJ, Syrigos KN et al. E-cadherin expression correlates with tumor differentiation in colorectal cancer. Hepatogastroenterology 1999;46:232-5.
6. Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJ. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997;112:46-54.
7. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 1999;80:1046-51.
8. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000;148:779-90.
9. Hazan RB, Kang L, Whooley BP, Borgen PI. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 1997;4:399-411.
10. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996;135:1643-54.
11. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-44.
12. Miettinen PJ, Ebner R, Lopez AR, Derynck R. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 1994;127:2021-36.
13. El-Hariry I, Pignatelli M, Lemoine NR. FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma. Int J Cancer 2001;94:652-61.
14. El-Hariry I, Pignatelli M, Lemoine NR. FGF-1 and FGF-2 modulate the E-cadherin/catenin system in pancreatic adenocarcinoma cell lines. Br J Cancer 2001;84:1656-63.
15. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer 1995;76:1671-7.
16. Griffin JF, Smalley SR, Jewell W, et al. Patterns of failure after curative resection of pancreatic carcinoma. Cancer 1990;66:56-61.
17. Cameron JL, Crist DW, Sitzmann JV, et al. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-4; discussion 124-5.
18. Imamura M, Hosotani R, Kogire M. Rationale of the so-called extended resection for pancreatic invasive ductal carcinoma. Digestion 1999;60(Suppl 1):126-9.
19. Nagakawa T, Mori K, Nakano T, et al. Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 1993;80:619-21.
20. Nakao A, Harada A, Nonami T, Kaneko T, Takagi H. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996;12:357-61.
21. Takahashi T, Ishikura H, Motohara T, Okushiba S, Dohke M, Katoh H. Perineural invasion by ductal adenocarcinoma of the pancreas. J Surg Oncol 1997;65:164-70.
22. Hirai I, Kimura W, Ozawa K, et al. Perineural invasion in pancreatic cancer. Pancreas 2002;24:15-25.
23. Redies C, Engelhart K, Takeichi M. Differential expression of N- and R-cadherin in functional neuronal systems and other structures of the developing chicken brain. J Comp Neurol 1993;333:398-416.
24. Knudsen KA, Soler AP, Johnson KR, Wheelock MJ. Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J Cell Biol 1995;130:67-77.
25. Geiger B, Ayalon O. Cadherins. Annu Rev Cell Biol 1992;8:307-32.
26. Salomon D, Ayalon O, Patel-King R, Hynes RO, Geiger B. Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 1992;102:7-17.
27. Sobin LH, Fleming ID. TNM classification of malignant tumors, Ed. 5. Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-4.
28. Japan Pancreatic Society. General rules for the study of pancreatic cancer. Tokyo: Kanehara Pub Co., 1993.
29. Wehner F, Wehner H, Schieffer MC, Subke J. Immunohistochemical detection of methadone in the human brain. Forensic Sci Int 2000;112:11-6.
30. Han AC, Peralta-Soler A, Knudsen KA, Wheelock MJ, Johnson KR, Salazar H. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol 1997;28:641-5.
31. Teraoka H, Sawada T, Yamashita Y, et al. TGF-beta1 promotes liver metastasis of pancreatic cancer by modulating the capacity of cellular invasion. Int J Oncol 2001;19:709-15.
32. So F, Daley TD, Jackson L, Wysocki GP. Immunohistochemical localization of fibroblast growth factors FGF-1 and FGF-2, and receptors FGFR2 and FGFR3 in the epithelium of human odontogenic cysts and tumors. J Oral Pathol Med 2001;30:428-33.
33. Tempia-Caliera AA, Horvath LZ, Zimmermann A, et al. Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002;79:93-100.
34. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
35. Frixen UH, Nagamine Y. Stimulation of urokinase-type plasminogen activator expression by blockage of E-cadherin-dependent cell-cell adhesion. Cancer Res 1993;53:3618-23.
36. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-19.
37. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993;5:806-11.
38. Birchmeier W, Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994;1198:11-26.
39. Birchmeier C, Birchmeier W, Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 1996;156:217-26.
40. Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-4.
41. Savagner P, Valles AM, Jouanneau J, Yamada KM, Thiery JP. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell 1994;5:851-62.
42. Savagner P, Yamada KM, Thiery JP. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 1997;137:1403-19.
43. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
44. Arias AM. Epithelial mesenchymal interactions in cancer and development. Cell 2001;105:425-31.
45. Riehl R, Johnson K, Bradley R, et al. Cadherin function is required for axon outgrowth in retinal ganglion cells in vivo. Neuron 1996;17:837-48.
46. Gumbiner BM. Regulation of cadherin adhesive activity. J Cell Biol 2000;148:399-404.
47. Welch DR, Fabra A, Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proc Natl Acad Sci USA 1990;87:7678-82.
48. Ueki N, Ohkawa T, Yokoyama Y, et al. Potentiation of metastatic capacity by transforming growth factor-beta 1 gene transfection. Jpn J Cancer Res 1993;84:589-93.